MedPath

An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss.

Active, not recruiting
Conditions
Overweight and Obesity
Registration Number
NCT07152470
Lead Sponsor
Prostasis, LLC, dba Tonum Health
Brief Summary

The goal of this clinical trial is to learn if motus, a natural supplement can support healthy weight loss and fat loss in a real world setting without caloric restrictions or exercise requirements.

The main questions it aims to answer are:

Can a daily dose of motus result in statistically significant weight loss over 3 month and 6 month time points.

Participants will:

Weigh-in at baseline and every week thereafter Take drug motus every day Complete a food tracker app for every meal and drink product consumed daily Complete an exercise tracker for any activities performed daily Complete weekly satisfaction surveys on various topics

Detailed Description

A prospective, observational human study was conducted with 100 participants (ages 25-68, BMI ≥25) over an initial 12-week period, followed by a 12-week extension phase for 40 continuing participants. All subjects received motus (4-capsule daily dose) and were instructed to track food intake and exercise via food tracker app and digital fat measurement scales. No caloric restriction was mandated, and participants could optionally receive nutritional counseling. Weekly weigh-ins and quality of life surveys were completed. No financial compensation was provided. Participants were stratified post hoc into three behavioral groups based on food and activity logs reviewed by registered dietitians: Category 1 (healthy diet + exercise 4+ times per week), Category 2 (average diet + exercise 2-3 times per week), Category 3 (average diet + no exercise) and Category 4 (poor diet + no exercise).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • BMI >25
  • Willing to complete daily diary and weekly weigh-ins
  • Willing to take motus daily
Exclusion Criteria
  • BMI<25
  • Unwilling to complete daily diary and weekly weigh-ins
  • Currently taking a prescribed weight loss medication
  • Currently or planning to be pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total Weight Loss26 weeks

Total weight loss as a percentage of total body weight

Body Fat Loss26 weeks

Total body fat loss compared to lean mass loss

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tonum Health

🇺🇸

West Palm Beach, Florida, United States

Tonum Health
🇺🇸West Palm Beach, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.